PT Jayamas Medica Industri Tbk (IDX:OMED)
290.00
-10.00 (-3.33%)
Apr 29, 2026, 4:06 PM WIB
IDX:OMED Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | 366,949 | 321,673 | 259,360 | 285,782 | 562,692 | Upgrade
|
| Depreciation & Amortization | 70,948 | 58,775 | 56,526 | 41,214 | 34,973 | Upgrade
|
| Other Amortization | 46.35 | 75.45 | 427.87 | 431.79 | 659.37 | Upgrade
|
| Other Operating Activities | -42,867 | -18,004 | -181,959 | -234,810 | -93,216 | Upgrade
|
| Operating Cash Flow | 395,077 | 362,519 | 134,354 | 92,617 | 505,108 | Upgrade
|
| Operating Cash Flow Growth | 8.98% | 169.82% | 45.06% | -81.66% | 81.22% | Upgrade
|
| Capital Expenditures | -108,126 | -102,323 | -156,385 | -75,068 | -82,722 | Upgrade
|
| Sale of Property, Plant & Equipment | 96.81 | 10.87 | 409.94 | 0.35 | 38.36 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -19.39 | -56.12 | -302.25 | -61.94 | Upgrade
|
| Investment in Securities | -113,289 | -61,819 | 420,440 | -419,477 | -104,310 | Upgrade
|
| Other Investing Activities | -7,761 | - | 185.15 | -251.91 | - | Upgrade
|
| Investing Cash Flow | -229,078 | -164,151 | 264,594 | -495,100 | -187,056 | Upgrade
|
| Long-Term Debt Issued | 189,199 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -174,602 | -17,265 | -25,307 | -36,342 | -17,972 | Upgrade
|
| Net Debt Issued (Repaid) | 14,597 | -17,265 | -25,307 | -36,342 | -17,972 | Upgrade
|
| Issuance of Common Stock | - | - | - | 780,579 | - | Upgrade
|
| Repurchase of Common Stock | -9,442 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -96,553 | -77,929 | -85,777 | -250,000 | -255,000 | Upgrade
|
| Other Financing Activities | -4,000 | - | 505 | -750 | -10,000 | Upgrade
|
| Financing Cash Flow | -95,397 | -95,195 | -110,578 | 493,486 | -282,972 | Upgrade
|
| Foreign Exchange Rate Adjustments | -17,604 | 959.27 | 1,654 | 6,704 | 731.57 | Upgrade
|
| Net Cash Flow | 52,997 | 104,133 | 290,023 | 97,708 | 35,812 | Upgrade
|
| Free Cash Flow | 286,951 | 260,196 | -22,031 | 17,549 | 422,386 | Upgrade
|
| Free Cash Flow Growth | 10.28% | - | - | -95.84% | 84.63% | Upgrade
|
| Free Cash Flow Margin | 13.90% | 13.80% | -1.27% | 1.01% | 18.97% | Upgrade
|
| Free Cash Flow Per Share | 10.61 | 9.62 | -0.81 | 0.65 | 15.61 | Upgrade
|
| Cash Interest Paid | 9,097 | 17,449 | 16,957 | 16,952 | 17,138 | Upgrade
|
| Cash Income Tax Paid | 71,626 | 2,422 | 76,907 | 193,043 | 142,710 | Upgrade
|
| Levered Free Cash Flow | 128,880 | 77,099 | -92,067 | 8,156 | 311,711 | Upgrade
|
| Unlevered Free Cash Flow | 139,706 | 89,455 | -79,829 | 21,159 | 325,362 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.